Last Updated: November 9, 2026

Patent: 7,851,446

Summary for Patent: 7,851,446

Title:	Use of therapeutic human albumin for treatment of alzheimer'S disease
Abstract:	The present invention relates to the use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders. In particular, the invention relates to methods of treating patients suffering from cognitive disorders, in which the mode of administration of the drug comprises the administration to the patient for a minimum of three successive times of a therapeutically effective amount of human therapeutic albumin by plasma exchange and/or intravenous perfusion, independently of the content of Aβ in the patient's blood.
Inventor(s):	Victor Grifols Roura
Assignee:	Grifols SA
Application Number:	US12/257,814
Patent Claims:	see list of patent claims

Details for Patent 7,851,446

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kedrion, S.p.a.	KEDBUMIN	albumin (human)	Injection	125384	June 03, 2011	7,851,446	2028-10-24
Kedrion Biopharma Inc.	KEDBUMIN	albumin (human)	Injection	125384	June 3, 2011	7,851,446	2028-10-24
Kedrion, S.p.a.	KEDBUMIN	albumin (human)	Injection	125384	September 05, 2013	7,851,446	2028-10-24
Kedrion Biopharma Inc.	KEDBUMIN	albumin (human)	Injection	125384	September 5, 2013	7,851,446	2028-10-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,851,446

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Argentina	068901	⤷ Start Trial
Australia	2008233025	⤷ Start Trial
Brazil	PI0804623	⤷ Start Trial
Canada	2641830	⤷ Start Trial
Chile	2008003133	⤷ Start Trial
China	101417123	⤷ Start Trial
European Patent Office	2111868	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.